ArticleJournal of bone oncology2021

Interleukin-24 inhibits the phenotype and tumorigenicity of cancer stem cell in osteosarcoma via downregulation Notch and Wnt/β-catenin signaling.

Baobiao Zhuo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.